Your browser doesn't support javascript.
loading
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer.
Imai, Hisao; Wasamoto, Satoshi; Yamaguchi, Ou; Suzuki, Kensuke; Sugiyama, Tomohide; Uchino, Junji; Minemura, Hiroyuki; Osaki, Takashi; Ishii, Hisashi; Umeda, Yukihiro; Mori, Keita; Kotake, Mie; Kagamu, Hiroshi; Morozumi, Nobutoshi; Taniguchi, Hirokazu; Kasai, Takashi; Minato, Koichi; Kaira, Kyoichi.
Afiliación
  • Imai H; Division of Respiratory Medicine, Gunma Prefectural Cancer Center, 617-1, Takahayashinishi, Ota, Gunma, 373-8550, Japan. m06701014@gunma-u.ac.jp.
  • Wasamoto S; Division of Respiratory Medicine, Saku Central Hospital Advanced Care Center, Saku, Nagano, Japan.
  • Yamaguchi O; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama University Hospital, Hidaka, Saitama, Japan.
  • Suzuki K; Division of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Toyama, Japan.
  • Sugiyama T; Division of Thoracic Oncology, Tochigi Cancer Center, Utsunomiya, Tochigi, Japan.
  • Uchino J; Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.
  • Minemura H; Department of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
  • Osaki T; Division of Respirology, National Hospital Organization Shibukawa Medical Center Hospital, Shibukawa, Gunma, Japan.
  • Ishii H; Department of Pulmonary Medicine, Nishisaitama-Chuo National Hospital, Tokorozawa, Saitama, Japan.
  • Umeda Y; Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Eiheiji, Fukui, Japan.
  • Mori K; Clinical Research Promotion Unit, Clinical Research Center, Shizuoka Cancer Center, Nagaizumi, Shizuoka, Japan.
  • Kotake M; Division of Respiratory Medicine, Gunma Prefectural Cancer Center, 617-1, Takahayashinishi, Ota, Gunma, 373-8550, Japan.
  • Kagamu H; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama University Hospital, Hidaka, Saitama, Japan.
  • Morozumi N; Division of Respiratory Medicine, Saku Central Hospital Advanced Care Center, Saku, Nagano, Japan.
  • Taniguchi H; Division of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Toyama, Japan.
  • Kasai T; Division of Thoracic Oncology, Tochigi Cancer Center, Utsunomiya, Tochigi, Japan.
  • Minato K; Division of Respiratory Medicine, Gunma Prefectural Cancer Center, 617-1, Takahayashinishi, Ota, Gunma, 373-8550, Japan.
  • Kaira K; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama University Hospital, Hidaka, Saitama, Japan.
J Cancer Res Clin Oncol ; 146(2): 457-466, 2020 Feb.
Article en En | MEDLINE | ID: mdl-31853661
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: J Cancer Res Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: J Cancer Res Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania